The Group's principal pharmaceutical manufacturing site. The premises measure 23,000 square metres, and the plant has a production capacity of 50 million units per year. It specializes in the manufacturing and packaging of oral solid, drops, injectables and topical formulations. Situated in Milan and licensed to produce pharmaceutical specialties for the major international markets, the plant is designed to ensure the highest manufacturing standards in compliance with CGMP (Current Good Manufacturing Practices) standards; it operates in conformity with the most stringent international environmental regulations.
Via Civitali, 1
20148 Milan, Italy
Tel. +39 02 487871
Fax. +39 02 48787264
Campoverde di Aprilia (Latina, Italy)
The high-tech facility covering an area of over 360,000 square metres, has an installed capacity of 800 cubic metres. There are produced, by chemical syntheses, active ingredients for Recordati pharmaceutical brands and of large-scale active ingredients and active ingredients for the international markets.
The plant operates in accordance with cGMP (current Good Manufacturing Practices) and in conformity with the most stringent international environmental regulations. It is regularly inspected by the FDA, by other national and international authorities as well as our customers.
The Plant Environmental Management System, has gotten the certification in 2003, according to the UNI EN ISO 14001: 1996 norm, subsequently confirmed according to UNI EN ISO 14001: 2004 norm.The Certification has been released by the International Accredited Unit DNV (Det Norske Veritas, Italy).
Via Mediana Cisterna, 4
04011 Campoverde di Aprilia (LT)
Tel. +39 06 92900010
Fax. +39 06 92902016
This is the pharmaceutical manufacturing facility of Bouchara Recordati. Covering an area of approximately 3,500 square metres, the plant is licensed to produce and package oral liquid, solid formulations and sprays. It has a manufacturing capacity of 30 million units per year. The plant is designed to ensure the highest manufacturing standards in compliance with GMP (Good Manufacturing Practices) standards; it operates in conformity with the most stringent international environmental regulations.
Bouchara Recordati S.a.s.
03410 Saint Victor, France
Tel. +33 4 70037900
Fax +33 4 70037890
Ringaskiddy, Cork (Ireland)
The site, which covers the area of 4.21 hectares, is located in the pharmaceutical industrial area of Ringaskiddy, approximately 15km from Cork, the second largest city in Ireland. The lercanidipine manufacturing facility became operational at the end of 2005. A GMP (Good Manufacturing Practices) certificate was issued by The Irish Medicines Board in December 2005.
Recordati Ireland Ltd.
Ringaskiddy, Co. Cork
Tel. +353 21 4379400
Fax +353 21 4379264